Navigation Links
American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillion's OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
Date:11/12/2013

WASHINGTON, Nov. 12, 2013 /PRNewswire/ --  A new study of OVA1® clinical performance in the presurgical detection of ovarian cancer, entitled "Clinical Performance of a Multivariate Index Assay For Detecting Early-Stage Ovarian Cancer," has been published in The American Journal of Obstetrics & Gynecology.

Led by Dr. Robert E. Bristow (UC Irvine Healthcare) and Dr. Frederick R. Ueland (U. Kentucky), the new analysis focuses on presurgical detection of early-stage ovarian cancer among 1,016 ovarian mass surgery patients in two previous pivotal trials conducted in 2007 and 2012.

The study compared OVA1 performance in early-stage ovarian cancer to commonly used cancer risk assessment protocols: overall clinical assessment, the CA125 biomarker or modified-American College of Obstetricians and Gynecologists (mod-ACOG) guidelines for evaluation of suspicious pelvic masses. Vermillion, Inc. (NASDAQ: VRML), the multivariate diagnostics company which developed and currently markets the test, reported the findings today at the American Association of Gynecologic Laparoscopists "42nd AAGL Global Congress on Minimally Invasive Gynecology."

"Early-stage ovarian cancer constitutes an important opportunity to improve survival and care for this most deadly gynecologic cancer," said Dr. Bristow. "However, as evidenced by recent studies, most ovarian cancer patients fail to be referred to the doctors and hospitals best equipped to treat them, resulting in unfortunate consequences.

"Our new study demonstrates OVA1's ability to detect the majority of all early-stage ovarian cancers prior to surgery and thereby aid in appropriately involving a gynecologic oncologist in their care. Even among premenopausal patients where primary
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
2. Latin American Peripheral Vascular Device Market Will Expand Strongly To reach Revenues of $335 Million in 2022
3. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
4. Imprimis Pharmaceuticals, Inc. Announces Its Attendance at the American Academy of Ophthalmology in New Orleans, Nov. 16-19
5. Gateway Analytical to Exhibit Pharmaceutical Forensic Services at the American Association of Pharmaceutical Scientist Annual Meeting in San Antonio
6. IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
7. NxStage Medical Introduces New Products at 2013 American Society of Nephrology Meeting
8. ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting
9. Stage at Breast Cancer Diagnosis Will Shift Dramatically Over the Next 20 Years in Key Latin American Markets
10. Upsher-Smith To Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures At 2013 American Epilepsy Society Meeting
11. American Capital Commits $391 Million in the Combination of Cambridge Major Laboratories and AAIPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... SAN FRANCISCO , May 5, 2015 ... a Small Business Innovation Research (SBIR) grant from the ... Creek is a San Francisco ... therapeutics to selectively repair tissues damaged by disease. This ... therapeutics engineered to repair heart tissue following a heart ...
(Date:5/5/2015)... , May 5, 2015 Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal, and metabolic diseases, today ... evaluating tenapanor in Stage 3 chronic kidney disease ... did not meet the primary endpoint of decreasing ... to patients receiving placebo. Ardelyx ...
(Date:5/5/2015)... , May 5, 2015 North ... $94.9 million in 2014, and is estimated to grow ... 7.8% from 2014 to 2019. Browse through ... Market for an analysis of industry trends and segments, ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early buyers ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3
... Further,Scientific Validation of the Potential Utility of Modigene,s CTP Technology ... ... -, VIENNA, Va., Sept. 24 Modigene Inc. (OTC,Bulletin Board: ... edition of the journal Endocrinology showing that,erythropoietin (EPO) linked to Modigene,s ...
... FRAMINGHAM, Mass., Sept. 24 Iodine has been ... has been written about molecular,iodine yet many women ... studies being conducted may soon yield an effective,nonhormonal ... drugs on the market, all,available hormonal therapies have ...
Cached Medicine Technology:Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 2Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 3Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 4Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease 2
(Date:5/5/2015)... Trail, NC (PRWEB) May 05, 2015 ... serving Indian Trail, Monroe, Matthews, Charlotte and surrounding areas. ... the field of accounting. This company provides assistance in ... priority as they prepare individual or corporate tax returns ... system in the cloud that allows clients (and Carlini ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 Leveraging ... Clinic in Greece, an experienced team of fertility ... of infertility for patients around the globe. , “We’re ... VisitandCare.com. Greece unquestionably remains a global leader in reproductive ... and hard-working fertility specialists in the world who play ...
(Date:5/5/2015)... From the halls of Microsoft Ignite ... enabling enterprise collaboration across platforms and devices, today ... and simplify the move to Microsoft Office 365. ... Office 365 enable organizations to migrate to ... adoption and effectively managing critical business data on ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dr. Patricia ... pulmonary hypertension (PH). A pulmonologist and pulmonary hypertension specialist ... was attending a work event when an initial idea ... “I was sitting in the audience at the 2010 ... team of healthcare providers – were recalling their climb ...
(Date:5/5/2015)... year, PolyU researchers garnered two Grand Prizes, two Special ... and four Silver Medals at the world-renowned event. The ... Prize and Gold Medal with the Congratulations of Jury:, ... Investigator: Dr Allan Chee-kooi CHAN, Institute of Textiles and ... the “mannequin” for many tasks involved in apparel design, ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5
... ... Benjamin was recently named to the advisory board for PerfectServe, a healthcare communications ... serving physician practices and hospitals nationwide. , ... Knoxville, Tenn. (PRWEB) September 15, 2009 -- ...
... , Peripheral Arterial Disease Coalition Joins ... Individuals and Healthcare System , , ... of the nation,s leading voices in the health disparities discussion, is ... code peripheral arterial disease (P.A.D.) prevalence down to the street ...
... BC, Sept. 15 /PRNewswire-FirstCall/ - avVaa World Health Care ... manufacturer and distributor of nationally branded therapeutic, natural skin ... first DRTV test week. , avVaa World Health Care ... Neuroskin(R) Psoriasis Relief DRTV media campaign. A total of ...
... , , , ... Susan Olmetti , one must only step forward into the ... of unconventional characters housed in an outlying charismatic Chicago suburb - a ... by more than 75 locally owned, independent businesses and a significant gay ...
... , , , EAST LANSING, ... of the American auto industry could affect United Auto Workers (UAW) ... Michigan State Medical Society and the Michigan Dental Association on Thursday, ... Showplace in Novi. , , Conference speakers will ...
... , LOS ANGELES, Sept. 15 In a market ... in for a challenge when he founded RED Light (R) ... business plan in place and the marketing vision to position RED Light ... elixir. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090915/AQ75816 ) , , ...
Cached Medicine News:Health News:Judy Benjamin Named to PerfectServe Advisory Board 2Health News:National Minority Quality Forum Creates Advanced, Precision Tracking Tool to Address Prevalence of Peripheral Arterial Disease 2Health News:National Minority Quality Forum Creates Advanced, Precision Tracking Tool to Address Prevalence of Peripheral Arterial Disease 3Health News:avVaa World Health Care Products, Inc. Announces DRTV Test Results 2Health News:avVaa World Health Care Products, Inc. Announces DRTV Test Results 3Health News:Wine Reception Mixing up one Part Abstract Artist Susan Olmetti, one Part Chicago House Fundraiser, and one Part SIR Spa 2Health News:'Future of Autos, Future of Health Care' to Be Examined by the Michigan State Medical Society and the Michigan Dental Association 2Health News:RED Light Energy Elixir is Enticing Consumers With its 'Original Seduction,' Positioning the Brand for Mounting Success 2
... guidewire-mounted pressure sensor and continues to ... the only sensor on the market ... With significantly improved maneuverability and pushability, ... guidewire, as well as a valuable ...
... Now you can perform stereotactic, ultrasound and ... convenience of your office. Use the patented, ... easier and more clinically advanced method of ... best for the women who trust YOU.,12 ...
... you can perform stereotactic, ultrasound and MRI-guided ... of your office. Use the patented, FDA-cleared ... and more clinically advanced method of breast ... for the women who trust YOU.,9 Gauge ...
... can perform stereotactic, ultrasound and MRI-guided vacuum ... your office. Use the patented, FDA-cleared ATEC ... more clinically advanced method of breast biopsy. ... the women who trust YOU.,9 Gauge Handpieces: ...
Medicine Products: